Relay Therapeutics prices IPO at $400M July 16, 2020 Auto Bot BioPharma, biopharma nl, Cambridge, initial public offering, Massachusetts 0 The company, whose drug-discovery efforts are focused on protein motion and detection of interactions that occur anywhere on a protein rather than only at active sites, filed to go public last month.